AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update

Alessio Aghemo, Angelo Armandi, Elisabetta Bugianesi, Giuseppe Cabibbo, Marco Carbone, Roberta D’Ambrosio, Andrea Dalbeni, Simone Di Cola, Antonio Gasbarrini, Giacomo Germani, Stefano Gitto, Massimo Iavarone, Fabio Marra, Mario Masarone, Giuseppe Marrone, Luca Miele, Grazia Pennisi, Salvatore Petta, Francesca Romana Ponziani, Federico Ravaioli, Francesco Paolo Russo, Francesco Tovoli, Luca Valenti, Umberto Vespasiani-Gentilucci, Mauro Vigano

Open source

DOI: 10.1016/j.dld.2026.02.014
Published: 2026-05
Container: Digestive and Liver Disease
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.dld.2026.02.014,
  title = {AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update},
  author = {Alessio Aghemo and Angelo Armandi and Elisabetta Bugianesi and Giuseppe Cabibbo and Marco Carbone and Roberta D’Ambrosio and Andrea Dalbeni and Simone Di Cola and Antonio Gasbarrini and Giacomo Germani and Stefano Gitto and Massimo Iavarone and Fabio Marra and Mario Masarone and Giuseppe Marrone and Luca Miele and Grazia Pennisi and Salvatore Petta and Francesca Romana Ponziani and Federico Ravaioli and Francesco Paolo Russo and Francesco Tovoli and Luca Valenti and Umberto Vespasiani-Gentilucci and Mauro Vigano},
  year = {2026},
  journal = {Digestive and Liver Disease},
  doi = {10.1016/j.dld.2026.02.014},
  url = {https://doi.org/10.1016/j.dld.2026.02.014}
}

RIS

TY  - JOUR
TI  - AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update
AU  - Alessio Aghemo
AU  - Angelo Armandi
AU  - Elisabetta Bugianesi
AU  - Giuseppe Cabibbo
AU  - Marco Carbone
AU  - Roberta D’Ambrosio
AU  - Andrea Dalbeni
AU  - Simone Di Cola
AU  - Antonio Gasbarrini
AU  - Giacomo Germani
AU  - Stefano Gitto
AU  - Massimo Iavarone
AU  - Fabio Marra
AU  - Mario Masarone
AU  - Giuseppe Marrone
AU  - Luca Miele
AU  - Grazia Pennisi
AU  - Salvatore Petta
AU  - Francesca Romana Ponziani
AU  - Federico Ravaioli
AU  - Francesco Paolo Russo
AU  - Francesco Tovoli
AU  - Luca Valenti
AU  - Umberto Vespasiani-Gentilucci
AU  - Mauro Vigano
PY  - 2026
JO  - Digestive and Liver Disease
DO  - 10.1016/j.dld.2026.02.014
UR  - https://doi.org/10.1016/j.dld.2026.02.014
ER  -

APA

Aghemo, A., Armandi, A., Bugianesi, E., Cabibbo, G., Carbone, M., D’Ambrosio, R., Dalbeni, A., Cola, S. D., Gasbarrini, A., Germani, G., Gitto, S., Iavarone, M., Marra, F., Masarone, M., Marrone, G., Miele, L., Pennisi, G., Petta, S., Ponziani, F. R., Ravaioli, F., Russo, F. P., Tovoli, F., Valenti, L., Vespasiani-Gentilucci, U., & Vigano, M. (2026). AISF practice guidance on pharmacological treatment of metabolic-dysfunction associated steatotic liver disease and steatohepatitis (MASLD/MASH): A 2026 Update. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.02.014

Source records

crossref · retrieved 2026-09-26T10:51:26.671Z